Inato
We're Hiring!
Inato Company Growth, Stability & Outlook
What People Are Saying About Inato
-
Market Expansion: The platform’s reported research-site network scaled from hundreds in 2022 to 6,000+ sites across 50+ countries, alongside a broader base of 25+ sponsors. Feedback suggests recent partnerships helped extend reach to additional site networks.
-
Product Line Growth: Inato moved beyond its original marketplace into AI-powered patient pre-screening and AI site-selection, with ongoing workflow integrations. These additions indicate continued investment in broader clinical-trial capabilities.
-
Strategic Partnerships: Collaborations such as the RealTime eClinical Solutions agreement and integrations with CRIO and other providers are described as expanding distribution and deepening ecosystem ties. Feedback suggests these relationships open pathways to thousands of affiliated sites and embed the platform more fully in site workflows.
